Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer

NCT01579188 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Inoperable Stage III Non-small Cell Lung Cancer

Interventions

DRUG: GV1001
DRUG: normal saline

Sponsor

Kael-GemVax Co., Ltd.

Collaborators

[object Object]